Ernie Shippey
- Co-authors
- Samuel F. HohmannAdam de HavenonMohammad AnadaniShadi YaghiDavid TirschwellHerbert D. AronowHafiz ImranAthena Poppas
- Topics
- COVID-19 and healthcare impacts (9 papers)Long-Term Effects of COVID-19 (4 papers)CAR-T cell therapy research (3 papers)
- Cited by
- OncologyNeurologyInfectious Diseases
- Partner nations
- United StatesIranTanzania
In The Last Decade
Ernie Shippey
19 papers receiving 294 citations
Peers
Comparison fields: 5 of 52
- Oncology 172
- Neurology 93
- Infectious Diseases 86
- Epidemiology 45
- Cardiology and Cardiovascular Medicine 40
Countries citing papers authored by Ernie Shippey
This map shows the geographic impact of Ernie Shippey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernie Shippey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernie Shippey more than expected).
Fields of papers citing papers by Ernie Shippey
This network shows the impact of papers produced by Ernie Shippey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernie Shippey. The network helps show where Ernie Shippey may publish in the future.
Co-authorship network of co-authors of Ernie Shippey
This figure shows the co-authorship network connecting the top 25 collaborators of Ernie Shippey. A scholar is included among the top collaborators of Ernie Shippey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernie Shippey. Ernie Shippey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 77 | |
| 11 | 15 | |
| 12 | 20 | |
| 13 | 6 | |
| 14 | 64 | |
| 15 | 3 | |
| 16 | 15 | |
| 17 | 1 | |
| 18 | 25 | |
| 19 | 9 | |
| 20 | 31 |
About Ernie Shippey
Ernie Shippey is a scholar working on Obstetrics and Gynecology, Applied Microbiology and Biotechnology and Oncology, having authored 24 papers that have together received 299 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (9 papers), Long-Term Effects of COVID-19 (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (172 citations), Neurology (93 citations) and Infectious Diseases (86 citations). Ernie Shippey has collaborated with scholars based in United States, Iran and Tanzania. Frequent co-authors include Samuel F. Hohmann, Adam de Havenon, Mohammad Anadani, Shadi Yaghi, David Tirschwell, Herbert D. Aronow, Hafiz Imran, Athena Poppas, Kevin Kennedy and J. Dawn Abbott. Their work appears in journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.